Hepatitis B virus in HIV-infected patients in northeastern South Africa: Prevalence, exposure, protection and response to HAART

South African Medical Journal

Volumn 103, Issue 5, 2013, Pages 330-333

  Ayuk, Julius ^a   Mphahlele, Jeffrey ^b   Bessong, Pascal ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF LIMPOPO   (South Africa)

^c UNIVERSITY OF VENDA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; EFAVIRENZ; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE PLUS STAVUDINE; NEVIRAPINE; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC IMAGING; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; SEROCONVERSION; SOUTH AFRICA; VIRUS LOAD;

EID: 84877679144     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.6304     Document Type: Article

References (19)

1. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 2010;14(12):e1024-1031. [http://dx.doi.org/10.1016/j.ijid.2010.06.013]
2. Compri AP, Miura I, Porta G, Lemos MF, Saraceni CP, Moreira RC. Hepatitis B virus infection in children, adolescents, and their relatives: genotype distribution and precore and core gene mutations. Rev Soc Bras Med Trop 2012;45:301-304. [http://dx.doi.org/10.1590/S0037-86822012000300004]
3. Komatsu H, Inui A, Sogo T, Tateno A, Shimokawa R, Fujisawa T. Tears from children with chronic hepatitis B virus (HBV) infection are infectious vehicles of HBV transmission: Experimental transmission of HBV by tears, using mice with chimeric human livers. J Infect Dis 2012 (Epub ahead of print). [http://dx.doi.org/10.1093/infdis/jis385]
4. Di Bisceglie AM, Maskew M, Schulze D, Reyneke A, McNamara L, Firnhaber C. HIV-HBV coinfection among South African patients receiving antiretroviral therapy. Antivir Ther 2010;15:499-503. [http://dx.doi.org/10.3851/IMP1494]
5. Audsley J, du Cros P, Goodman Z, et al. HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection. J Med Virol 2012;84:993-1001. http://dx.doi.org/10.1002/jmv.23236]
6. Chun HM, Roediger MP, Hullsiek KH, et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis 2012;205:185-193. [http://dx.doi.org/10.1093/infdis/jir720]
7. Mallet V, Vallet-Pichard A, Pol S. The impact of human immunodeficiency virus on viral hepatitis. Liver International 2011;31:135-139. [http://dx.doi.org/10.1111/j.1478-3231.2010.02394.x]
8. Boyles TH, Cohen K. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J 2011;27:470-471.
9. Hoffman CJ, Charalambous S, Martin DJ, et al. Hepatitis B infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008;47:1479-1485. [http://dx.doi.org/10.1086/593104]
10. Burnett RJ, Ngobeni JM, François G, et al. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD and AIDS 2007;18:152-156. [http://dx.doi.org/10.1258/095646207780132523]
11. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 2000;77:13-15.
12. Lukhwareni A, Burnett RJ, Selabe GS, Mzileni MO, Mphahlele MJ. Increased Detection of HBV DNA in HBsAg-Positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a tertiary hospital. J Med Virol 2009;82:406-412. [http://dx.doi.org/10.1002/jmv.21418]
13. Firnhaber C, Reyneke A, Schultz D, et al. The prevalence of hepatitis B co-infection in a South African urban HIV clinic. S Afr Med J 2008;98:541-544.
14. Chemin I, Trepo C. Clinical impact of occult HBV infection. J Clin Virol 2005;34:S15-S21.
15. Mayaphi SH, Roussow TM, Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. S Afr Med J 2012;102:157-162.
16. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006;35:14-20. [http://dx.doi.org/10.1016/j.jcv.2005.04.003]
17. Hoffman CJ, Charalambous S, Martin DJ, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and Hepatitis B. AIDS 2007;21:1301-1308. [http://dx.doi.org/10.1097/QAD.0b013e32814e6b08]
18. Sulkowsky MS, Thomas DL, Chaisson RE, Moore R. Hepatotoxicity associated with anti-retroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80. [http://dx.doi.org/10.1001/jama.283.1.74]
19. Mathews GV, Bartholomeusz A, Locarnini S, et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV infected individuals on extended lamivudine therapy. AIDS 2006 20:863-867. [http://dx.doi.org/10.1097/01.aids.0000218550.85081.59.]